Management of Treatment-Naïve Genotypes 2 and 3 HCV Infection
Last updated: July 9, 2013
A 55-year-old man presents for evaluation of his hepatitis C (HCV). He feels well and denies any history of gastrointestinal bleeding, encephalopathy, or abdominal swelling. His serum aminotransferase levels (ALT and AST) are 3 to 4 times greater than the upper limits of normal. Serum albumin, total bilirubin, alkaline phosphatase, and prothrombin time all are normal. Further testing reveals a HCV RNA level of 3 million IU/ml and HCV genotype 2 infection.
Which of the following statements is TRUE regarding therapy in such cases?